MedTrace Logo

Endometrioma Per se Versus Treatment Related Reduction in Ovarian Reserve (ERROR-2 Trial)

NCT03620838 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2019-10-10

No results posted yet for this study

Summary

The present multi-center study aimed to evaluate whether endometrioma-associated decline in ovarian reserve is progressive in the absence of an intervention and is greater in magnitude than the natural decline over time. Also the affect of endometrioma treatment modalities like surgery or medical on the ovarian reserve over time.

Conditions

  • Ovarian Reserve
  • Endometrioma

Interventions

DRUG

oral contraceptive pill, oral progesterone

ovarian endometrioma cyst excision

Sponsors & Collaborators

  • Uludag University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-03-01
Primary Completion
2020-09-01
Completion
2020-09-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03620838 on ClinicalTrials.gov